Exogenous estrogen enhances T cell activation in male primates

Estrogen influences T cell development and enhances infection resistance in females, but its immunological effects during gender-affirming hormone therapy (GAHT) remain poorly understood. Here, we characterize immune adaptations in male rhesus macaques (RMs) treated with 17β-estradiol (E2) or placebo over 7 months. E2 therapy suppressed endogenous testosterone production, induced female physical traits, and altered blood cell counts and chemistry profiles. Additionally, E2 treatment attenuated innate immune responses while increasing T cell activation. Following mRNA vaccination, E2-treated RMs exhibited significantly higher frequencies of CCR5<sup>+</sup> CD4<sup>+</sup> T cells, the primary targets for HIV-1 replication, compared to placebo-treated RMs. Overall, our findings reveal the immunological consequences of estrogen in male primates, emphasizing the need to investigate how supraphysiological E2 levels may affect HIV susceptibility and pathogenesis. This work highlights the potential of RMs as a model for studying immune interventions in the context of GAHT.

Authors

Institutions

Publication Details

Journal
Cell Reports
Published
2025-08-22
DOI
https://doi.org/10.1016/j.celrep.2025.116170
Citations
2
Primary Topic
Reproductive System and Pregnancy
Type
article
Field-Weighted Citation Impact
1.59

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exogenous estrogen enhances T cell activation in male primates

Eva G. Rakasz, P. Hahn, Camila Rosat Consiglio, Michael D. Cameron et al.
2 citations
Cell Reports
Reproductive System and Pregnancy
1.59
article

Exogenous estrogen enhances T cell activation in male primates

Eva G. Rakasz, P. Hahn, Camila Rosat Consiglio, Michael D. Cameron, Maurício A. Martins, Michael Farzan, Tianling Ou, Saverio Capuano, Noah J. Gurley, Eric S Alexander, K. Weisgrau, Wenhui He, Lin Li, Joe R Kurian, Derek T. O’Hagan, Joan Escrivà-Font
article en
2 citations

Abstract

Estrogen influences T cell development and enhances infection resistance in females, but its immunological effects during gender-affirming hormone therapy (GAHT) remain poorly understood. Here, we characterize immune adaptations in male rhesus macaques (RMs) treated with 17β-estradiol (E2) or placebo over 7 months. E2 therapy suppressed endogenous testosterone production, induced female physical traits, and altered blood cell counts and chemistry profiles. Additionally, E2 treatment attenuated innate immune responses while increasing T cell activation. Following mRNA vaccination, E2-treated RMs exhibited significantly higher frequencies of CCR5<sup>+</sup> CD4<sup>+</sup> T cells, the primary targets for HIV-1 replication, compared to placebo-treated RMs. Overall, our findings reveal the immunological consequences of estrogen in male primates, emphasizing the need to investigate how supraphysiological E2 levels may affect HIV susceptibility and pathogenesis. This work highlights the potential of RMs as a model for studying immune interventions in the context of GAHT.

Cell ReportsVol. 44(9)
Broad Institute (US), Scripps Research Institute (US), Boston Children's Hospital (US), University of Wisconsin–Madison (US), Lund University (SE), The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology
University of Miami, Vetenskapsrådet, Science for Life Laboratory, National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development
Zero hunger
Openalex Percentile: Top 15%
Reproductive System and Pregnancy
1.59
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.